Clinical Trials Logo

Stage IV Prostate Cancer AJCC v7 clinical trials

View clinical trials related to Stage IV Prostate Cancer AJCC v7.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02565901 Terminated - Clinical trials for Metastatic Prostate Carcinoma

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Start date: February 29, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This partially randomized phase I/II trial studies the side effects and how well sirolimus works when given together with docetaxel and carboplatin in treating patients with castration-resistant prostate cancer that has spread to other places in the body (metastatic). Biological therapies, such as sirolimus, use substances made from living organisms that may stimulate or suppress the immune system in different ways and stop tumor cells from growing. Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving sirolimus together with docetaxel and carboplatin may kill more tumor cells.